APOTEX INC FDA Approval ANDA 201950

ANDA 201950

APOTEX INC

FDA Drug Application

Application #201950

Application Sponsors

ANDA 201950APOTEX INC

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORALEQ 0.5MG BASE0RASAGILINE MESYLATERASAGILINE MESYLATE
002TABLET;ORALEQ 1MG BASE0RASAGILINE MESYLATERASAGILINE MESYLATE

FDA Submissions

N/A; Not ApplicableORIG1AP2013-09-12

Submissions Property Types

ORIG1Null19

CDER Filings

APOTEX INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201950
            [companyName] => APOTEX INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"RASAGILINE MESYLATE","activeIngredients":"RASAGILINE MESYLATE","strength":"EQ 0.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RASAGILINE MESYLATE","activeIngredients":"RASAGILINE MESYLATE","strength":"EQ 1MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/12\/2013","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"12\/17\/2015","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2015-12-17
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.